NRx Pharmaceuticals
NRXP

NRx Pharmaceuticals (NRXP) earnings history

Most recent quarter

Period end
Dec 31, 2025
EPS estimate
−$0.07
EPS surprise
+114.29%
Revenue
$991,500.00
Reported
Mar 23, 2026

Earnings history

PeriodReportedEPS estimateEPS actualSurpriseRevenueFiling
Q4 2025Mar 23, 2026−$0.07$0.01+114.29%$991,500.00SEC
Q3 2025Nov 14, 2025−$0.13−$0.27−105.79%$242,000.00SEC
Q2 2025Aug 18, 2025−$0.15−$0.98−552.46%$0.00SEC
Q1 2025May 15, 2025−$0.28−$0.34−20.01%$2.3MSEC
Q4 2024Mar 14, 2025−$0.37−$0.72−97.52%$0.00SEC
Q3 2024Nov 14, 2024−$0.56−$0.15+72.97%$0.00SEC
Q2 2024Aug 14, 2024−$0.70−$0.75−7.91%$0.00SEC
Q1 2024May 14, 2024−$0.55−$0.74−34.55%$0.00SEC
Q4 2023Mar 29, 2024−$0.70−$0.50+28.57%$0.00SEC
Q3 2023Nov 14, 2023−$1.10−$0.70+36.36%$0.00SEC
Q2 2023Aug 14, 2023−$1.33−$1.20+10.00%$0.00SEC
Q1 2023May 15, 2023−$1.35−$1.60−18.52%$0.00SEC
Q4 2022Mar 31, 2023−$1.45−$1.50−3.45%$0.00SEC
Q3 2022Nov 14, 2022−$1.40−$1.40+0.00%$0.00
Q2 2022Aug 15, 2022−$1.00−$1.10−10.00%$0.00
Q1 2022May 16, 2022$0.00−$2.10+0.00%$0.00

Quarterly revenue

Q1 2022
$0.00
Q2 2022
$0.00
Q3 2022
$0.00
Q4 2022
$0.00
Q1 2023
$0.00
Q2 2023
$0.00
Q3 2023
$0.00
Q4 2023
$0.00
Q1 2024
$0.00
Q2 2024
$0.00
Q3 2024
$0.00
Q4 2024
$0.00
Q1 2025
$2.3M
Q2 2025
$0.00
Q3 2025
$242,000.00
Q4 2025
$991,500.00

Frequently asked questions

  • When did NRx Pharmaceuticals (NRXP) last report earnings?

    NRx Pharmaceuticals last reported on Mar 23, 2026, covering fiscal Q4 2025.

  • Did NRXP beat earnings estimates?

    Yes. NRx Pharmaceuticals reported EPS of $0.01 for Q4 2025 against a −$0.07 estimate — a 114.29% beat.

  • How much revenue did NRXP report last quarter?

    NRx Pharmaceuticals reported $991,500.00 in revenue for Q4 2025, against a consensus estimate of $3.6M.

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.